Literature DB >> 3884734

The toxic role of alpha-haemolysin in the pathogenesis of experimental Escherichia coli infection in mice.

H W Smith, M B Huggins.   

Abstract

Filtrates from strains of Escherichia coli possessing plasmid-cloned haemolysin (Hly) genes and from strains possessing 'wild' Hly plasmids were lethal for mice on intravenous inoculation; similar doses of preparations from derivatives of these strains in which the Hly genes had been rendered non-functional or which did not possess the 'wild' plasmids were not. Live cultures of both kinds of Hly+ strain usually had a lower lethal dose for mice on intraperitoneal inoculation than the corresponding Hly- forms. Mice that had been inoculated with Hly+ forms had shorter survival times and lower numbers of organisms in peritoneal washings, lungs and blood at point of death than mice that had been inoculated with the corresponding Hly- forms; this was also so for mice pre-treated with FeSO4, a procedure which rendered mice equally susceptible to the lethal effects of the Hly+ and Hly- forms of a strain. In FeSO4-treated mice the numbers of organisms in the tissues of those dying from infection with Hly+ organisms were no higher than they were at the same time after inoculation in others given the corresponding Hly- forms; before mice of the latter category died the numbers of organisms in their tissues increased greatly. The clinical and pathological signs exhibited by mice inoculated with Hly+ organisms, but not with Hly- organisms, resembled those exhibited by mice inoculated with bacteria-free haemolysin preparations. These results suggest that haemolysin played a significant role in the pathogenesis of the disease produced by the Hly+ organisms by having a direct toxic action on the host.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884734     DOI: 10.1099/00221287-131-2-395

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  10 in total

Review 1.  The different hemolysins of Escherichia coli.

Authors:  L Beutin
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

Review 2.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

3.  Deletions affecting hemolytic and toxin activities of Bordetella pertussis adenylate cyclase.

Authors:  J Bellalou; H Sakamoto; D Ladant; C Geoffroy; A Ullmann
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

4.  Survey of purported virulence factors of Escherichia coli isolated from blood, urine and stool.

Authors:  S M Opal; A Cross; P Gemski; L W Lyhte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

5.  Large, unstable inserts in the chromosome affect virulence properties of uropathogenic Escherichia coli O6 strain 536.

Authors:  S Knapp; J Hacker; T Jarchau; W Goebel
Journal:  J Bacteriol       Date:  1986-10       Impact factor: 3.490

Review 6.  Some infectious causes of diarrhea in young farm animals.

Authors:  R E Holland
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

Review 7.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

8.  Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains.

Authors:  H L Mobley; D M Green; A L Trifillis; D E Johnson; G R Chippendale; C V Lockatell; B D Jones; J W Warren
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

9.  Calcium is required for binding of Escherichia coli hemolysin (HlyA) to erythrocyte membranes.

Authors:  D F Boehm; R A Welch; I S Snyder
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

10.  Contribution of cloned virulence factors from uropathogenic Escherichia coli strains to nephropathogenicity in an experimental rat pyelonephritis model.

Authors:  R Marre; J Hacker; W Henkel; W Goebel
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.